Corporate venture capital groups deployed $1.6 billion to the startup ecosystem in 232 deals during the second quarter of 2015.
According to the MoneyTree Report™ from PricewaterhouseCoopers LLP and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters, the 132 combined corporate venture groups accounted for 9.2% of total venture dollars invested and participated in 19.3% of the deals for the quarter.
This represented the strongest quarter, by number of deals, since the third quarter of 2008 when corporate venture accounted for 24% of all venture deals.
Software companies led the way, receiving $1.5 billion in 207 deals through the first half of 2015, representing 40% of overall corporate venture investing.
Second was the industrial/energy sector which received $1.0 billion in 23 deals, accounting for 27% of overall corporate venture investing and 59% of total venture capital investment in the sector.
Biotechnology companies received the third largest total investment amount by corporate venture groups so far in 2015 with $513 million going into 60 deals, representing 13.4% of overall corporate venture investing.
Corporate venture investing in the life sciences sector, which includes biotechnology and medical devices, totaled $584 million in 79 deals coming from 39 corporate ventures groups through the first half of the year.
Download the report here.